Altimmune, Inc.
ALT
$5.61
-$0.36-6.03%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -7.48% | -31.93% | -24.64% | -8.68% | -4.41% |
| Total Depreciation and Amortization | 129.10% | 167.87% | -357.63% | -267.54% | -265.92% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -51.70% | 148.13% | 174.30% | 132.61% | 188.83% |
| Change in Net Operating Assets | 154.12% | 142.86% | 284.94% | -120.26% | -158.64% |
| Cash from Operations | -5.33% | -2.00% | -0.48% | -6.27% | -21.13% |
| Capital Expenditure | -- | 100.00% | 100.00% | 102.38% | 62.70% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -306.01% | -319.61% | -569.35% | 34.75% | 118.81% |
| Cash from Investing | -306.71% | -320.43% | -555.74% | 34.94% | 118.71% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -87.48% | 415.36% | 61.20% | 60.20% | 51.82% |
| Repurchase of Common Stock | 16.99% | 20.41% | 29.42% | -13.79% | -98.45% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -100.00% | -100.00% | 267.03% | -- |
| Cash from Financing | -88.34% | 446.39% | 63.10% | 61.63% | 51.64% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -508.67% | -36.39% | -35.00% | 65.84% | 130.34% |
